The Federal Bureau of Investigation and attorneys with the US Justice Department are considering Snapchat’s "role" in fentanyl-laced pills in the US "as part of a broader probe into the deadly counterfeit drugs crisis," wrote Olivia Carville, Jason Leopold and Maria Curi wrote for Bloomberg. "On Wednesday, the involvement of technology companies in the ongoing fentanyl crisis will be discussed on Capitol Hill at a House Energy and Commerce Committee roundtable," noted the Bloomberg story. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNAP:
- MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward
- JPMorgan calls out Meta as top pick ahead of earnings from online ads group
- #SocialStocks: Meta fights scraping, Twitter interest payments coming due
- Snap downgraded to Mixed from Positive view at OTR Global
- Snap downgraded to Market Perform from Outperform at JMP Securities